LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Expansions Jazz Pharmaceuticals has been making strategic moves in recent months, including investments from Algert Global LLC and SEC, as well as promoting key personnel like Samantha Pearce to chief commercial officer. These expansions indicate potential growth opportunities for sales and partnerships.

Mergers & Acquisitions Jazz Pharmaceuticals sold assets to Axsome Therapeutics Inc. in the past, showcasing a proactive approach towards mergers and acquisitions. This history suggests a willingness to engage in further M&A activities, presenting opportunities for sales around collaboration or new product lines.

Commitment to Innovation With a focus on developing life-changing medicines for serious diseases, Jazz Pharmaceuticals demonstrates a strong commitment to innovation. This dedication can be leveraged to create sales narratives around cutting-edge treatments and solutions, appealing to healthcare providers and patients alike.

Financial Stability Jazz Pharmaceuticals falls within the revenue range of $100M - 1B, indicating healthy financial standing. This stability can be used as a leverage point in sales discussions, showcasing reliability and capacity for sustained partnerships or investments.

Market Positioning In the realm of pharmaceutical manufacturing, Jazz Pharmaceuticals competes with companies like Canopy Growth Corporation, Zynerba Pharmaceuticals, and Cara Therapeutics. Understanding the competitive landscape can help identify market niches or opportunities to differentiate products, enhancing sales strategies.

Similar companies to GW Pharmaceuticals plc

GW Pharmaceuticals plc Tech Stack

GW Pharmaceuticals plc uses 8 technology products and services including Bloomberg, Databricks, Alation, and more. Explore GW Pharmaceuticals plc's tech stack below.

  • Bloomberg
    Accounting And Finance
  • Databricks
    Big Data Processing
  • Alation
    Data Management
  • Microsoft Excel
    Editors
  • Oracle
    Enterprise
  • Selenium
    Frameworks And Libraries
  • Java
    Programming Languages
  • Google Tag Manager
    Tag Management

Media & News

GW Pharmaceuticals plc's Email Address Formats

GW Pharmaceuticals plc uses at least 2 format(s):
GW Pharmaceuticals plc Email FormatsExamplePercentage
FLast@gwpharm.comJDoe@gwpharm.com
85%
First.Last@gwpharm.comJohn.Doe@gwpharm.com
11%
FirstL@gwpharm.comJohnD@gwpharm.com
2%
First-Last@gwpharm.comJohn-Doe@gwpharm.com
1%
FL@gwpharm.comJD@gwpharm.com
1%
First.Last@jazzpharma.comJohn.Doe@jazzpharma.com
78%
FLast@jazzpharma.comJDoe@jazzpharma.com
20%
First.Middle@jazzpharma.comJohn.Michael@jazzpharma.com
2%

Frequently Asked Questions

Where is GW Pharmaceuticals plc's headquarters located?

Minus sign iconPlus sign icon
GW Pharmaceuticals plc's main headquarters is located at Sovereign House, Vision Park Chivers Way, Histon Cambridge, CB24 9BZ GB. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is GW Pharmaceuticals plc's phone number?

Minus sign iconPlus sign icon
You can contact GW Pharmaceuticals plc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is GW Pharmaceuticals plc's stock symbol?

Minus sign iconPlus sign icon
GW Pharmaceuticals plc is a publicly traded company; the company's stock symbol is GWPH.

What is GW Pharmaceuticals plc's official website and social media links?

Minus sign iconPlus sign icon
GW Pharmaceuticals plc's official website is jazzpharma.com and has social profiles on LinkedIn.

How much revenue does GW Pharmaceuticals plc generate?

Minus sign iconPlus sign icon
As of October 2024, GW Pharmaceuticals plc's annual revenue reached $750M.

What is GW Pharmaceuticals plc's SIC code NAICS code?

Minus sign iconPlus sign icon
GW Pharmaceuticals plc's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 325412 - Pharmaceutical Preparation Manufacturing.

How many employees does GW Pharmaceuticals plc have currently?

Minus sign iconPlus sign icon
As of October 2024, GW Pharmaceuticals plc has approximately 1K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Operating Officer: C. T.Chief Operating Officer: C. T.Vice President Us Marketing: B. R.. Explore GW Pharmaceuticals plc's employee directory with LeadIQ.

What industry does GW Pharmaceuticals plc belong to?

Minus sign iconPlus sign icon
GW Pharmaceuticals plc operates in the Pharmaceutical Manufacturing industry.

What technology does GW Pharmaceuticals plc use?

Minus sign iconPlus sign icon
GW Pharmaceuticals plc's tech stack includes BloombergDatabricksAlationMicrosoft ExcelOracleSeleniumJavaGoogle Tag Manager.

What is GW Pharmaceuticals plc's email format?

Minus sign iconPlus sign icon
GW Pharmaceuticals plc's email format typically follows the pattern of . Find more GW Pharmaceuticals plc email formats with LeadIQ.

How much funding has GW Pharmaceuticals plc raised to date?

Minus sign iconPlus sign icon
As of October 2024, GW Pharmaceuticals plc has raised $345M in funding. The last funding round occurred on Oct 02, 2018 for $345M.
GW Pharmaceuticals plc

GW Pharmaceuticals plc

Pharmaceutical ManufacturingCambridge, United Kingdom1001-5000 Employees

GW Pharmaceuticals is now part of Jazz Pharmaceuticals. Follow us at https://www.linkedin.com/company/jazz-pharmaceuticals 


Section iconCompany Overview

Headquarters
Sovereign House, Vision Park Chivers Way, Histon Cambridge, CB24 9BZ GB
Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
GWPH
NAICS Code
325412 - Pharmaceutical Preparation Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $345M

    GW Pharmaceuticals plc has raised a total of $345M of funding over 6 rounds. Their latest funding round was raised on Oct 02, 2018 in the amount of $345M.

  • $100M$1B

    GW Pharmaceuticals plc's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $345M

    GW Pharmaceuticals plc has raised a total of $345M of funding over 6 rounds. Their latest funding round was raised on Oct 02, 2018 in the amount of $345M.

  • $100M$1B

    GW Pharmaceuticals plc's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.